Skip to main content

Pharmacy

By Susan Morse | 11:28 am | January 11, 2023
COVID-19 vaccines are moving towards commercial prices set by Moderna and Pfizer.
By Jeff Lagasse | 03:18 pm | January 09, 2023
Synergie aims to significantly reduce medical benefit drug costs by establishing a more efficient contracting model.
By Susan Morse | 04:02 pm | January 06, 2023
Retail pharmacies can now sell abortion pills under new FDA modifications.
By Jeff Lagasse | 03:50 pm | January 05, 2023
CMS concurs with OIG's recommendation and says it will determine whether additional guidance would help ensure more accurate ASP calculations.
By HIMSS TV | 06:00 am | January 04, 2023
<p>Naomi Fried, PharmStars' founder and CEO, discusses the company's spring 2023 cohort, and its call for applications to digital health groups across the world who focus on women's health and health equity for underserved populations.</p>
By Susan Morse | 11:06 am | January 03, 2023
The drug was estimated to cost Medicare $12B in one year, representing 36% of the 2018 Part B budget.
By Susan Morse | 10:53 am | December 29, 2022
The XBB variant, which is resistant to immunity, now makes up over half of cases in New England.
By Susan Morse | 10:35 am | December 21, 2022
The issue is one of demand, not supply, experts say.
By Jeff Lagasse | 03:02 pm | December 19, 2022
Overall, 51% of enrolled patients using Adstiladrin therapy achieved a complete response, with all signs of cancer disappearing.
By Jeff Lagasse | 02:41 pm | December 07, 2022
The companies hope the treatment will provide greater efficacy as the virus evolves and proves increasingly resistant to current therapies.